Agilon Health (AGL) reported Tuesday a Q4 net loss from continuing operations of $0.26 per share, narrowing from a loss of $0.41 a year earlier.
Analysts polled by FactSet expected a loss of $0.24.
Revenue for the quarter ended Dec. 31 was $1.52 billion, up from $1.06 billion a year earlier.
Analysts surveyed by FactSet expected $1.52 billion.
For Q1, the company expects revenue of $1.48 billion to $1.52 billion. Analysts polled by FactSet expect $1.61 billion.
For 2025, Agilon expects revenue of $5.83 billion to $6.03 billion. Analysts surveyed by FactSet expect $6.41 billion.
The company's share price fell more than 15% in Wednesday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.